Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Rigel Pharmaceuticals, Inc.”

373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 373
Index total 30,257
Page 4 / 16

Quick answer

This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

373 results for “Rigel Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 10493066

    Fumarate analogs and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted
  2. US 10479783

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Nov 19, 2019 · Expires Nov 14, 2039

    granted
  3. US 10450280

    Tetrazolones as a carboxylic acid bioisosteres

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted
  4. US 10434096

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  5. US 10421752

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  6. US 10414758

    Compounds and method for treating autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  7. US 10414753

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  8. US 10377742

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  9. US 10369148

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  10. US 10370367

    IRAK inhibitors and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted
  11. US 10357505

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted
  12. US 10314840

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted
  13. US 10287295

    TGF-β inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  14. US 10259826

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted
  15. US 10233170

    2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  16. US 10208074

    Pyrazole compounds and method for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  17. US 10208075

    Pyrazole compounds and method for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted
  18. US 10166216

    Substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted
  19. US 10130623

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted
  20. US 10065946

    Benzazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted
  21. US 10040766

    Ubiquitination inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted
  22. US 10005777

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  23. US 10005767

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  24. US 9982000

    Pyrazole compounds and method for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted